Ixabepilone
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 424 publications
Folic acid-conjugated biopolymeric nanoparticles for targeted delivery of ixabepilone in breast cancer.
Journal: Preparative biochemistry & biotechnology
Published: February 09, 2026
Folic acid-targeted chitosan-alginate blend nanoparticles for enhanced ixabepilone delivery and antitumor efficacy in breast cancer.
Journal: International journal of biological macromolecules
Published: December 18, 2025
Meta-Analysis and Experimental Studies Reveal Mitotic Network Activity Index (MNAI) as Breast Cancer Metastasis and Treatment Biomarker.
Journal: Life (Basel, Switzerland)
Published: October 27, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 29, 2025
Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer.
Journal: Medicine
Published: January 14, 2025
Convergent Total Synthesis of Ixabepilone and Its Analogues Enabled by Highly Efficient Asymmetric Hydrogenations.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 17, 2024
Targeted and cytotoxic inhibitors used in the treatment of breast cancer.
Journal: Pharmacological research
Published: November 28, 2024
Clinical Manifestations of Neuropathic Pain and the Deleterious Effects of Chemotherapeutic Agents.
Journal: Current drug safety
Published: June 20, 2024
Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole Bioisosterism.
Journal: ChemPlusChem
Published: June 12, 2024
Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy.
Journal: Advances in experimental medicine and biology
Published: May 28, 2024
Ixabepilone related angiographically silent macular edema.
Journal: European journal of ophthalmology
Published: May 03, 2024
Last Updated: 04/28/2026